In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & Johnson), also carries a first-line indication for transplant-ineligible MM ...
EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old: Paris Monday, September 23, 2024, 11:00 ...
AM(IST)on Monday in an upbeat market. Glenmark Pharmaceuticals Ltd.(up 6.99 per cent), Mankind Pharma Ltd.(up 3.47 per cent), ...
The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S Food and Drug ...
Earlier switch to atezolizumab after run-in with vemurafenib plus cobimetinib showed promise in improving OS rates in BRAF ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Discover why LRLCF is a promising investment opportunity with solid earnings stability, competitive advantages, and sustained ...
The state has further attempted to regulate PBMs since passing Act 900. In May 2022, the state sued the drug manufacturers ...
BEIJING, CHINA - Media OutReach Newswire - 18 September 2024 - On September 12, the 2024 China International Fair for Trade in Services officially kicked off. The Beijing Economic-Technological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback